Validación del FINDRISC (FINnish Diabetes Risk SCore) para la predicción del riesgo de diabetes tipo 2 en una población del sur de España. Estudio Pizarra
Abstract
Background and objective The aim of this study was to validate the ability of the Finnish Diabetes Risk Score (FINDRISC) to predict the risk of DM2 in a population of south-eastern Spain (Pizarra Study). Subjects and methods The Pizarra Study is a population-based prospective study developed in the town of Pizarra (Málaga). The first phase of the study was conducted in 1997-1998, including 1051 individuals aged 18-65 years randomly selected from the municipal census of the town. In 2003-2004 the subjects participating in the first study were reassessed. 824 individuals completed the second phase of the study (78.4%). All participants without known diabetes underwent an oral glucose tolerance test both at baseline and follow-up. We evaluated the ability of the FINDRISC to detect undiagnosed DM2 (first phase: cross-sectional study) and in predicting the incidence of DM2 (second phase: cohort study). Results The test showed good results both to detect undiagnosed DM2 (ROC-AUC 0.74) and to predict incident DM2 (ROC-AUC 0.75). The best prediction of risk of incident DM2 was found in those subjects with fasting glucose >100mg/dl and a FINDRISC ≥9 (OR: 19.37; 95%IC: 8,86-42,34; P Conclusions The results of our study show that FINDRISC can be a useful tool to detect subjects at high risk of diabetes in this population.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
FINDRISC is the most commonly evaluated diabetes risk score worldwide and has been recommended as the best available risk assessment tool for clinical practice by a systematic review.
“Moreover, FINDRISC is the most commonly evaluated diabetes risk score worldwide [17,18,19,20,21,22,23,24,25] and has been recommended as the best available risk assessment tool for use in the clinical practice by a systematic review [11].”
From A Novel Testing Model for Opportunistic Screening of Pre-Diabetes and Diabetes among U.S. Adults (2015) · cites this paper as [20]
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works
Gillies, C. L., Abrams, K. R., Lambert, P. C., Cooper, N. J., Sutton, A. J., Hsu, R. T., & Khunti, K. (2007) · BMJ · doi:10.1136/bmj.39063.689375.55 · Cited by 1,171 · see citing works
Lin, J.-W., Chang, Y.-C., Li, H.-Y., Chien, Y.-F., Wu, M.-Y., Tsai, R.-Y., Hsieh, Y.-C., Chen, Y.-J., Hwang, J.-J., & Chuang, L.-M. (2009) · Diabetes Care · doi:10.2337/dc09-0694 · Cited by 60 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Zhang, L., Zhang, Z., Zhang, Y., Hu, G., & Chen, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097865 · Cited by 130 · see citing works
Gómez-Arbeláez, D., Alvarado-Jurado, L., Ayala-Castillo, M., Forero-Naranjo, L., Camacho, P. A., & López-Jaramillo, P. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i17.1337 · Cited by 58 · see citing works
Ku, G., & Kegels, G. (2013) · Primary Care Diabetes · doi:10.1016/j.pcd.2013.07.004 · Cited by 53 · see citing works
Salinero-Fort, M., Burgos-Lunar, C., Lahoz, C., Mostaza, J., Abánades-Herranz, J. C., Laguna-Cuesta, F., Cabo, E. E., García-Iglesias, F., González-Alegre, T., Fernández-Puntero, B., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158489 · Cited by 52 · see citing works
Janghorbani, M., Adineh, H., & Amini, M. (2013) · The review of diabetic studies : RDS · doi:10.1900/rds.2013.10.283 · Cited by 46 · see citing works
A Novel Testing Model for Opportunistic Screening of Pre-Diabetes and Diabetes among U.S. Adults
Zhang, Y., Hu, G., Zhang, L., Mayo, R., & Chen, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120382 · Cited by 41 · see citing works
Mata‐Cases, M., Artola, S., Escalada, J., Loiola, P. E., Ferrer-García, J. C., Fornos, J. A., Girbés, J., & Rica, I. (2015) · Atención Primaria · doi:10.1016/j.aprim.2014.12.002 · Cited by 8 · see citing works
Meijnikman, A. S., Block, C. D. D., Verrijken, A., Mertens, I., Corthouts, B., & van Gaal, L. (2016) · Journal of diabetes and its complications · doi:10.1016/j.jdiacomp.2016.05.004 · Cited by 34 · see citing works
Impact of sex and age on the performance of FINDRISC: the HUNT Study in Norway
Jølle, A., Midthjell, K., Holmen, J., Tuomilehto, J., Carlsen, S. M., Shaw, J. E., & Åsvold, B. O. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000217 · Cited by 29 · see citing works
Silvestre, M. P., Jiang, Y., Volkova, K., Chisholm, H., Lee, W., & Poppitt, S. D. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.07.003 · Cited by 27 · see citing works
Finnish Diabetes Risk Score to predict type 2 diabetes in the Isfahan diabetes prevention study.
Janghorbani, M., Adineh, H., & Amini, M. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.018 · Cited by 30 · see citing works
Mata‐Cases, M., Artola, S., Escalada, J., Loiola, P. E., Ferrer-García, J. C., Fornos, J. A., Girbés, J., & Rica, I. (2015) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2014.10.008 · Cited by 6 · see citing works
Salinero-Fort, M., de Burgos-Lunar, C., Prieto, J. M., Rallo, C. L., Abánades-Herranz, J. C., Gómez-Campelo, P., Cuesta, F. L., Estirado-Decabo, E., Iglesias, F. G., Alegre, T. G., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007195 · Cited by 24 · see citing works
Davies, M. J., Gray, L. J., Ahrabian, D., Carey, M., Farooqi, A. M., Gray, A. M., Goldby, S., Hill, S., Jones, K. L., Leal, J., et al. (2017) · Programme Grants for Applied Research · doi:10.3310/pgfar05020 · Cited by 24 · see citing works
Nieto-Martinez, R., Barengo, N., Restrepo, M., Grinspan, A., Assefi, A., & Mechanick, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1188784 · Cited by 20 · see citing works
Tan, C., Sasagawa, Y., Kamo, K., Kukitsu, T., Noda, S., Ishikawa, K., Yamauchi, N., Saikawa, T., Noro, T., Nakamura, H., et al. (2016) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-016-0568-5 · Cited by 22 · see citing works
“various countries and the questionnaire is now accepted and utilized worldwide [19, 20].”
BackgroundKiss, L. Z., Bagyura, Z., Vadas, R., Polgár, L., Lux, Á., Édes, E., Szenczi, O., Soós, P., Szelid, Z., Becker, D. J., et al. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.05.007 · Cited by 20 · see citing works
Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2020
Orozco-Beltrán, D., Cuixart, C. B., Sánchez, J. J. A., Banegas, J. R. B., Cebrián-Cuenca, A., Guillen, V. G., Rioboó, E. M., & Pérez, J. N. (2020) · Atención Primaria · doi:10.1016/j.aprim.2020.08.002 · Cited by 17 · see citing works
Prevención en diabetes mellitus y riesgo cardiovascular: enfoque médico y nutricional
Pinilla-Roa, A. E., & Barrera, M. D. P. (2018) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v66n3.60060 · Cited by 58 · see citing works
Risøy, A. J., Kjome, R., Sandberg, S., & Sølvik, U. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191316 · Cited by 15 · see citing works
A Risk Assessment Model for Type 2 Diabetes in Chinese
Luo, S., Han, L., Zeng, P., Chen, F., Pan, L., Wang, S., & Zhang, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104046 · Cited by 13 · see citing works
Riise, H., Graue, M., Igland, J., Birkeland, K., & Kolltveit, B. H. (2023) · BMC Primary Care · doi:10.1186/s12875-023-02100-x · Cited by 14 · see citing works
Conceição, A. L. O., Côrrea, N. D. C., Ferreira, P. R., Rêgo, A., Silva, F. B., de Carvalho, S. A. T. D., Dias, R. D. S., Paz, B. K. B., Rocha, V. C. D. C., & Bassi-Dibai, D. (2020) · Sao Paulo medical journal = Revista paulista de medicina · doi:10.1590/1516-3180.2019.0524.05032020 · Cited by 14 · see citing works
Muñoz-González, M. C., Lima-Martínez, M. M., Nava, A., Trerotola, G., Paoli, M., Cabrera-Rego, J. O., Gonzalez, B., Arciniegas, A., & Paez, J. (2019) · Medical Principles and Practice · doi:10.1159/000499468 · Cited by 12 · see citing works
Leung, A. Y. M., Xu, X., Chau, P. H., Yu, E. Y. T., Cheung, M. K. T., Wong, C. K. H., Fong, D., Wong, J. Y. H., & Lam, C. L. K. (2018) · JMIR mhealth and uhealth · doi:10.2196/10662 · Cited by 13 · see citing works
Mata‐Cases, M., Artola, S., Escalada, J., Loiola, P. E., Ferrer-García, J. C., Fornos, J. A., Girbés, J., & Rica, I. (2015) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2014.12.001 · Cited by 14 · see citing works
Acosta-Reyes, J. L., Garrido, D. P. R., Acosta, T., Aschner, P. J., Fraga, C. A., Vázquez‐Fernández, A., Tuomilehto, J. O., & Gabriel, R. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112480 · Cited by 14 · see citing works
Mugume, I. B., Wafula, S. T., Kadengye, D. T., & van Olmen, J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0276858 · Cited by 13 · see citing works
Llauradó, G., Cedó, L., Climent, E., Badia, J., Rojo-Martínez, G., Roux, J. A. F.-L., Yanes, O., Vinaixa, M., Granado-Casas, M., Mauricio, D., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04186-9 · Cited by 10 · see citing works
“The baseline clinical characteristics of subjects in the pre-sent study were used to estimate their risk of developing T2D according to the Finnish Diabetes Risk Score (FIN-DRISK) [18], previously validated for the Spanish population [19].”
Prevención de la diabetes mellitus tipo 2
Soriguer, F., Rubio‐Martín, E., & Rojo‐Martínez, G. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2012.03.015 · Cited by 12 · see citing works
Self-citationJin, S., Chen, Q., Han, X., Liu, Y., Cai, M., Zheng, Y., & Lü, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.725314 · Cited by 8 · see citing works
Moldobaeva, M. S., Виноградова, А. В., & Esenamanova, M. K. (2017) · High Altitude Medicine & Biology · doi:10.1089/ham.2017.0036 · Cited by 13 · see citing works
Rodríguez-Pérez, M., Orozco-Beltrán, D., Gil-Guillén, V., Domínguez-Coello, S., Almeida-González, D., Brito-Díaz, B., Marcelino-Rodriguez, I., Carratalá-Munuera, M., Gómez-Moreno, N., Navarro-Pérez, J., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.05.009 · Cited by 7 · see citing works
Recomendaciones preventivas vasculares. Actualización PAPPS 2024
Orozco‐Beltrán, D., Brotons-Cuixart, C., Banegas, J. R., Gil-Guillén, V. F., Cuenca, A. M. C., Martín-Rioboó, E., Jordá-Baldó, A., Vicuña, J., & Navarro-Pérez, J. (2024) · Atención Primaria · doi:10.1016/j.aprim.2024.103123 · Cited by 7 · see citing works
Relationship between healthy habits and sociodemographic variables and risk of diabetes type 2
González, Á., Sbert, P. R., Fe, B. R., Fe, N. R., Bote, S. A., & Manent, J. I. R. (2022) · African Health Sciences · doi:10.4314/ahs.v22i4.17 · Cited by 6
Rodriguez, M. G., Saldaña, M. R., Leyva, J. M. A., Rojas, R., & Molina-Recio, G. (2019) · Health Care for Women International · doi:10.1080/07399332.2019.1680678 · Cited by 6
Kestel, F. (2005) · TEPEXI Boletín Científico de la Escuela Superior Tepeji del Río · doi:10.1016/s0212-5382(05)71416-3 · Cited by 5
Salinero-Fort, M. Á., Mostaza-Prieto, J. M., Lahoz, C., Cárdenas‐Valladolid, J., Iriarte-Campo, V., Estirado, E., García-Iglesias, F., González-Alegre, T., Fernández-Puntero, B., Río, V. C.-D., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-083121 · Cited by 5 · see citing works
“Nevertheless, further studies can be conducted in different settings to address the observed limitations and improve its accuracy.”
BackgroundEsteban, D. O., Martin-Ridaura, C., Berlinches-Zapero, C., Ruiz-Fernández, D., Sanz-Martín, V., Gavira-Izquierdo, R., Muñoz-Haba, A., March, S., & Ceinos-Arcones, M. (2023) · Nutrients · doi:10.3390/nu15040841 · Cited by 4 · see citing works
“The inclusion criteria to enter the programme were to be over 18 years of age and have one of the following: a BMI over 30 or BMI between 27 and 30 with an abdominal circumference risk (greater than 88 cm in women or 102 cm in men) or a FINDRISC (Finnish type 2 Diabetes Risk Score) greater than 14, this instrument hav…”
MethodMartin-Ridaura, C., Ochoa-Esteban, D., Berlinches-Zapero, C., Ruiz-Fernández, D., Sanz-Martín, V., Gavira-Izquierdo, R., March, S., López-Toribio, M., Ceinos-Arcones, M., Rivas-Hernández, D., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-21531-7 · Cited by 4 · see citing works
Risco de desenvolvimento do diabetes tipo 2 em enfermeiras e sua relação com alterações metabólicas
Sánchez-Jiménez, B., Chico‐Barba, G., Rodríguez-Ventura, A. L., Sámano, R., Veruete-Bedolla, D., & Morales‐Hernández, R. M. (2019) · Revista Latino-Americana de Enfermagem · doi:10.1590/1518-8345.3002.3161 · Cited by 13 · see citing works
“This instrument was validated for use in Spanish(16) and has already been used in other studies in Mexico(17–19).”
MethodEl estudio Di@bet.es, ¿y ahora qué?
Soriguer, F., Valdés, S., & Rojo, G. (2012) · Avances en Diabetología · doi:10.1016/j.avdiab.2012.06.001 · Cited by 4 · see citing works
Self-citationCreating a Lifestyle Medicine Center: From Concept to Clinical Practice
Mechanick, J., & Kushner, R. (2020) · doi:10.1007/978-3-030-48088-2 · Cited by 4
New Simplified Diagnostic Decision Trees for the Detention of Metabolic Syndrome in the Elderly
Rodríguez-Guerrero, E., Romero-Saldaña, M., Fernández-Carbonell, A., Molina-Luque, R., & Molina-Recio, G. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17145191 · Cited by 3 · see citing works
“The individuals were asked if they did a moderate–intense physical activity of ≥30 min/day and consumed fruit and vegetables daily, both questions taken from the FINRISK questionnaire [14].”
Detection of people at risk of diabetes in community pharmacies of Pontevedra (Spain) (DEDIPO).
Fornos-Pérez, J., Andrés-Rodríguez, N. F., Andrés-Iglesias, J., Luna-Cano, R., García-Soidán, J., Lorenzo-Veiga, B., Mera-Gallego, R., & García-Riestra, R. (2016) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2016.10.002 · Cited by 3 · see citing works
Mata‐Cases, M., Artola, S., Escalada, J., Loiola, P. E., Ferrer-García, J. C., Fornos, J. A., Girbés, J., & Rica, I. (2014) · Revista Clínica Española · doi:10.1016/j.rce.2014.10.012 · Cited by 15 · see citing works
Corrigan, D., Taweel, A., Fahey, T., Arvanitis, T. N., & Delaney, B. (2014) · doi:10.24105/ejbi.2014.10.1.5 · Cited by 3
Transcultural Lifestyle Medicine
Nieto-Martínez, R. E., & Gonzalez-Rivas, J. P. (2020) · Springer eBooks · doi:10.1007/978-3-030-48088-2_19 · Cited by 4 · see citing works
Navarro-Cerdán, J., Pons-Suñer, P., Arnal, L., Arlandis, J., Llobet, R., Perez-Cortes, J., Lara-Hernández, F., Moya-Valera, C., Quiroz-Rodriguez, M. E., Rojo-Martínez, G., et al. (2025) · Medical and Biological Engineering and Computing · doi:10.1007/s11517-025-03355-5 · Cited by 2 · see citing works
Self-citationTure, N., Emecen, A. N., & Unal, B. (2025) · Primary Health Care Research and Development · doi:10.1017/s1463423625000180 · Cited by 2 · see citing works
“However, FINDRISC demonstrated similar performance in the majority of studies, including Malaysia (AUC: 0.76) (Lim et al ., 2020), Spain (AUC: 0.75) (Salinero-Fort et al. , 2016), Norway (AUC: 0.77) (Jølle et al. , 2019), and a European cohort (AUC: 0.74) (Gabriel et al. , 2021).”
InfluentialMetabolic syndrome index measurement tool (MSI): scale development, reliability and validity study
Akeren, Z., & Apaydın, E. (2025) · BMC Public Health · doi:10.1186/s12889-025-21304-7 · Cited by 2 · see citing works
“In addition, the scale [50, 51], which has been adapted to different cultures around the world, was first developed as a diabetes risk test, but is also used to assess the risk of MetS [52].”
Prevalence of prediabetes in an urban Nigerian population using the Finnish Diabetes Risk Score
Sowunmi, O. S., & Bhakta, D. (2022) · North African Journal of Food and Nutrition Research · doi:10.51745/najfnr.6.14.144-153 · Cited by 2
Ramírez-Durán, M. D. V., Basilio-Fernández, B., Gómez-Luque, A., Alfageme-García, P., Clavijo-Chamorro, M., Jiménez-Cano, V. M., Fabregat-Fernández, J., Robles-Alonso, V., & Hidalgo-Ruíz, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12101669 · Cited by 2 · see citing works
Nuñez, J. D. B., Rondón, J. C., Arciniega, E. P., & Núñez, N. B. (2022) · Revista de Salud Pública · doi:10.15446/rsap.v24n4.75956 · Cited by 2
Prediabetes: what are we talking about?
Escalada, J. (2021) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2021-0034 · Cited by 2 · see citing works
Validation of DIABSCORE in screening for Type 2 Diabetes and prediabetes in Tunisian population
Gannar, F., Rodríguez-Pérez, M. D. C., Coello, S. D., Haouet, K., Díaz, B. B., & de León, A. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200718 · Cited by 2 · see citing works
Protocolo sobre manejo de la diabetes mellitus tipo 2
Loiola, P. E., Loiola, P. E., Agirre, A. E., Idarreta, I., Gea, L. B., Baquedano, M. M., Asumendi, P. D., Canibe, I. V., & Etxeandia‐Ikobaltzeta, I. (2015) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2015.04.002
Hemos de utilizar herramientas para la valoracion del riesgo de diabetes mellitus en España
Puig-Domingo, M. (2012) · Medicina clínica (Ed. impresa) · doi:10.1016/j.medcli.2011.09.028 · Cited by 1 · see citing works
“En este contexto, en el presente número de Medicina Clı́nica, Soriguer et al.(9) nos ofrecen su experiencia en la utilización del FINDRISC score(10) para evaluar su utilidad en la predicción de DM en nuestro paı́s.”
BackgroundInfluentialLizarzaburu-Robles, J. C., Garro-Mendiola, A., Lazo-Porras, M., Sanz-Pastor, A. G., Vento, F., & Lorenzo, O. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.09.011 · Cited by 1 · see citing works
Asencio-Barrientos, C., García-Rodas, Ó. L., Chang-Chang, C., Torres-Salazar, L. C., Cifuentes-Alvarado, M., & Barrios-Lupitou, L. (2022) · Ciencia, Tecnología y Salud · doi:10.36829/63cts.v9i1.812 · Cited by 1 · see citing works
“…de esta varía de acuerdo a la región, en 2021 se estima que 6.7 millones de adultos entre 20 y 79 años murieron como resultado de la diabetes o sus complicaciones (Sun et al., 2022) y fue responsable de aproximadamente 4.2 millones de muertes de personas entre 20 y 79 años en el 2019 (IDF, 2021).”
BackgroundInfluentialMontoya, P. A., Múñoz, Ó., Cardozo, D. M. G., García, O. M., Fernandez-Ávila, D. G., Casas, L. Á., Bohórquez, L. F., Toro, C. M. A., Carvajal, L., de Peña, D. R., et al. (2016) · Colombia medica · doi:10.25100/cm.v47i2.2207 · Cited by 60 · see citing works
Estimating Gestational Diabetes: FINDRISC Score
Pekkolay, Z. (2018) · doi:10.14744/ejmi.2018.42714 · Cited by 1
Díaz, C., Álvarez-Ochoa, R., Faicán-Rocano, P. F., Cordero, G., & Barrera, J. M. L. (2026) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2026.102526
Montoya-Álvarez, L., Rodriguez-Sepúlveda, E., Galeano-Páez, C., Bru-Cordero, O., & Alcala-Tafur, N. (2026) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph23060811
“Subsequently, the FINDRISC questionnaire was applied, which has been previously validated by Soriguer et al. [25] and approved by the FID to detect the presence of risk of T2DM [26].”
Reiván-Ortiz, G., Gómez, M. Q., Campoverde, A., Yanza, R., Maraver-Capdevila, L., & Granero, R. (2026) · Scientific Reports · doi:10.1038/s41598-026-43873-2
Jansana, M. D. M., López, P. J. T., Miquel, J. J. G., López-González, Á., Sbert, P. R., Busquets-Cortés, C., & Ramírez-Manent, J. I. (2025) · Diabetology · doi:10.3390/diabetology6100109
“Among the most widely used tools are the Finnish Diabetes Risk Score (Findrisc), the Q Diabetes Risk Score (QDScore), and the Canadian Diabetes Risk Questionnaire (CANRISK) [16–18].”
Fornos-Pérez, J. A., Mera-Gallego, I., Magariños, I. J., Royo, J. H., Mera-Gallego, R., & Rodríguez, N. F. A. (2024) · Farmacéuticos Comunitarios · doi:10.33620/fc.2173-9218.(2024).03 · Cited by 1 · see citing works
“En el estudio de Soriguer et al., de referencia por haber sido realizado en población española, la prevalencia del riesgo alto/muy alto fue del 14,1 %, en una muestra entre 18 y 65 años (13); y en el más cercano en tiempo, también en Espa-ña, el estudio Detecta Sucre (23) encontraron un 17,9 % de personas con riesgo a…”
BackgroundRiesgo cardiovascular en pacientes con FINDRISC-C mayor o igual a 12
Santana, K. L. C., Cantillo, H. J. M., Romero, D. F. O., Restrepo, H. K. C., Fernández, E. A. T., & Caballero, H. G. Y. (2023) · Revista Repertorio de Medicina y Cirugía · doi:10.31260/repertmedcir.01217372.1028
Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2022
Orozco‐Beltrán, D., Cuixart, C. B., Banegas, J. R., Gil-Guillén, V. F., Cuenca, A. M. C., Rioboó, E. M., Baldó, A. J., Vicuña, J., & Pérez, J. N. (2022) · Atención Primaria · doi:10.1016/j.aprim.2022.102444 · Cited by 21 · see citing works
Prediabetes ¿de qué estamos hablando?
Escalada, J. (2021) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2021-0030
Mugume, I. B., Wafula, S. T., Kadengye, D., & van Olmen, J. V. (2021) · Research Square · doi:10.21203/rs.3.rs-414395/v1
RIESGO DE DIABETES EN ANCIANOS QUE RESIDEN EN UNA ZONA VULNERABLE DE LIMA NORTE
Artezano, A. R. (2020) · Ágora Revista Científica · doi:10.21679/arc.v7i1.140
“Se utilizó como guía para nuestro análisis de datos un instructivo del instrumento FINDRISC, el cual da precisiones de la forma como se valora el riesgo de diabetes tipo 2 (13,14).”
BackgroundUtility Of Finnish Diabetes Risk Score In A Young Adult Population In An Urban Setting In Africa
Malindisa, E., Balandya, E., Mashili, F., & Njelekela, M. (2019) · doi:10.21203/rs.2.14608/v1
Importance of Rational Screening for Type 2 Diabetes
V, E. (2016) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2016.03.00074
Riesgo cardiovascular y de diabetes en población carcelaria de Pereira, Colombia, 2010
Ochoa-Orozco, S. A., Moreno-Gutiérrez, P. A., Echeverri-Cataño, L. F., Orozco-Escobar, A., Mondragón-Cardona, Á., & Villegas-Rojas, S. (2012) · Revista Médica de Risaralda · doi:10.22517/25395203.7947
- Authors
- Soriguer, F., Valdés, S., Tapia, M. J., Esteva, I., Ruiz de Adana, M. S., Almaraz, M. C., Morcillo, S., García Fuentes, E., Rodríguez, F., & Rojo-Martinez, G.
- Affiliations
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
- Corresponding author
- Soriguer, Federico
- Venue
- Medicina Clínica
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 138
- Issue
- 9
- Pages
- 371-376
- ISSN
- 0025-7753 (ISSN-L)
- OpenAlex
- W1984142743
- Cited by
- 87
- References
- 0
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 6 · 2023: 6 · 2022: 10 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 5 · 2016: 11 · 2015: 10 · 2014: 6 · 2013: 3 · 2012: 3
- FWCI
- 3.41
- Type
- journal article
- Language
- es
- Open access
- closed
- Locations
- Medicina Clínica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- FINDRISC, type 2 diabetes, diabetes risk prediction, risk score validation, undiagnosed diabetes, diabetes incidence, fasting blood glucose, southeastern Spain
- MeSH terms
- Adolescent, Adult, Aged, Anthropometry, Blood Glucose, Diabetes Mellitus, Type 2, Fasting, Female, Follow-Up Studies, Glucose Tolerance Test, Humans, Hypertension, Male, Middle Aged, Models, Biological, Obesity, Prospective Studies, Sampling Studies, Severity of Illness Index, Spain, Comorbidity, Body Mass Index, Dyslipidemias, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
